The article by Gan et al provides the first important evidence that there is a genotypic correlation with phenotype in the lungs of patients with cystic fibrosis.' This finding will be considered in the light of (1) the basic abnormality in cystic fibrosis, (2) how the more than 400 mutations now identified in the cystic fibrosis gene relate to this basic abnormality, (3) the data prior to this publication regarding the link of these mutations with clinical disease, and (4) how the information provided in this paper alters this information.
Cystic fibrosis: the basic defect The cystic fibrosis (CF) gene on chromosome 7 codes for a protein entitled cystic fibrosis transmembrane conductance regulator (CFTR).' Numerous studies have shown that this protein acts as a chloride channel in the epithelium of the respiratory and intestinal tracts as well as in other epithelial-lined organs. 3 Whilst the precise function of chloride transport in these organs is unclear, the most probable current hypothesis relates to the concomitant movement ofwater that will osmotically follow chloride secretion. Thus, for example, in the airway epithelium, chloride movement from the inside of the cell on to the airway surface will be followed by water ( fig 1A) , and it is probable that this water contributes importantly to the sol layer component of the airway surface liquid. In subjects with cystic fibrosis the CFTR chloride channel does not function normally ( fig 1B) , leading to reduced water movement, an altered sol layer and, consequently, impaired mucociliary clearance. This represents one way in which impaired chloride secretion may relate to the recurrent infection to which these patients are susceptible.
However, it is important to mention two other possible links to pathogenesis. Firstly, both in the upper and lower airways of these patients the absorption of sodium ions from the mucosal surface into the cell is increased compared with subjects without cystic fibrosis (fig 1 B) .' fensin-like molecules are produced in cystic fibrosis, they do not appear to function normally with respect to killing P aeruginosa in the presence of these increased concentrations of salt. This abnormality could be reversed by returning the sodium and chloride concentrations towards normal levels. Thus, mutations in the CFTR gene cause a variety of malfunctions and the sequence of events from altered chloride transport to respiratory failure is only gradually being pieced together. This leads, by osmosis, to increased absorption of water and will further exacerbate the problem caused by the reduced chloride secretion on to the mucosal surface. The link between this secondary abnormality and the primary defect is uncertain but there is compelling evidence that both abnormalities are present. 5 Interestingly, this correlation with intestinal function is also carried through into the recently generated mouse models of cystic fibrosis. Thus, "null" mice which produce no CFTR protein, equivalent to a type 1 mutation, show marked intestinal problems resulting from a condition similar to meconium ileus, which result in the death ofthese animals early in their life time. In contrast, the recently generated G55 ID mouse (type 3 mutation) shows a markedly reduced incidence of such intestinal blockage and consequently prolonged survival.
Until the publication of the paper by Gan et al' the available data showed that, with respect to lung disease, there was, however, no correlation between genotype and phenotype."' This was irrespective of whether the mutation was, for example, a class 4 "mild" mutation, the "mild" relating to pancreatic disease but not to lung disease. These findings of a lack of correlation between genotype and phenotype in the lung have been confirmed in a large number of studies. The reasons for this discrepancy between the respiratory and intestinal tracts are not clear, but include a number ofpossibilities. One important feature is that, in the intestinal tract, CFTR represents the predominant and, in some cases, the only chloride channel present. To correlate with this, the level of CFTR protein is relatively higher in the intestine than in the respiratory tract."' In contrast, in the airways it is clear that there are a number of different chloride channels present, some of which are not regulated through an intracellular increase in cAMP, the mediator that regulates CFTR. Secondly, as noted above, sodium absorption may also play a part in disease pathogenesis in the lungs. Whilst some studies have shown increased sodium absorption in the small intestine of patients with cystic fibrosis,'6 this is not a consistent finding. Further, as noted above, colonisation with Pseudomonas clearly plays an important part in disease progression. This and other environmental factors may be crucial to the differences between the intestinal and respiratory tracts. Finally, the expression of genes other than that for CFTR may also have a role in disease pathogenesis, and such expression may be organ-specific. In summary, therefore, the role of CFTR in the airways may be less directly related to chloride transport than in the intestinal tract, and involve linkage with a number of different steps along the pathway of disease pathogenesis. This may, in turn, relate to the absence of genotype/phenotype correlations within the lung.
Novel findings of the paper by Gan et al The key finding of the paper by Gan et all is the identification of a mutation, A455E, that does appear to correlate with better lung prognosis. The mutation is clearly a "mild mutation" with respect to intestinal disease and, indeed, the patients in this study showed a markedly reduced degree of pancreatic insufficiency compared with AF508 homozygotes. Lung function was significantly higher in age and sex matched patients than in AF508 homozygotes, fewer patients were colonised with Pseudomonas, and disease was diagnosed at a later age in the subjects with A455E mutation. As LEARNING POINTS * The CF gene product CFTR functions as a chloride channel in epithelial cells. * The link between CFTR dysfunction and disease pathogenesis is unclear; altered mucociliary clearance and/or changes in bacterial clearance may be key mechanisms. * Several hundred CF mutations have been identified and produce varying levels of CFTR chloride function. * Correlations between this function and disease severity have previously been demonstrated in the intestinal tract.
* The paper by Gan et aI provides the first evidence for such a correlation for the lung.
noted above, such findings have not so far been identified and are obviously important for a number of reasons. Firstly, from the viewpoint of the patients and their relatives, identification of this mutation may suggest an improved prognosis. Clearly, however, the validity of such a prediction is difficult to gauge until larger numbers have been assessed, and it may be prudent to await such studies before placing overemphasis on information given to patients. Further, whilst the mutation is relatively common in Holland (around 7%), being second only in prevalence to AF508, the frequency worldwide is probably less than 1%. Secondly, from a mechanistic point of view it will be important to understand why the A455E mutation differs from others in predicting a favourable outcome. The ameliorating effects of this mutation may occur at one or more of the interactions of CFTR noted above. Thus, it will be important to know if the level of sodium absorption in the lungs of these subjects differs from that seen with other mutations, and to establish whether the number ofasialoGMi receptors or the composition of the airway surface liquid differs. One final consideration relates to the level of chloride secretion present in patients with the A455E mutation, which has been shown to allow residual se- Figure 3 shows that the relationship is not linear, with small increases in CFTR mRNA producing disproportionately larger increases in both chloride secretion and, in turn, survival. A455E may produce a small increase in function above a critical level, resulting, in turn, in a disproportionately large increase in function sufficient to influence lung disease. Finally, it is worth noting that, given the relative rarity of some mutations, A455E may not turn out to be the only mutation associated with an improved respiratory prognosis.
